Riskpilot← Back to searchSign inGet full accessVETTRE LEGEKONTOR AS
ASActiveOrg 916533012Konglungveien 202, 1392 VettreGeneral medical practice activities · NACE 8621Est. 20166 employeeswww.vettrelegekontor.no
Revenue 2024
NOK 2,3M
0% vs 2023
EBITDA margin
-2.4%
-132% vs 2023
Equity ratio
37.6%
Financial strength
Net profit 2024
NOK -88K
-175% vs 2023
| Revenue | NOK 2,3M | +0% |
| EBITDA | NOK -54K | -132% |
| Net profit | NOK -88K | -175% |
| Total assets | NOK 468K | -14% |
| Equity | NOK 176K | -33% |
| Employees | 6 | — |
Legal name
VETTRE LEGEKONTOR AS
Org number
916533012
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
12. januar 2016
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg
Company purpose
Drift av legekontor samt nærliggende virksomhet.
Address
Konglungveien 202, 1392 Vettre
Phone
+4766782459
Website
www.vettrelegekontor.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 014 | 1 734 | 1 953 | 2 260 | 2 259 |
| Staff expenses | −1 035 | −858 | −1 019 | −1 088 | −1 147 |
| EBITDA | 199 | 89 | −52 | 168 | −54 |
| Depreciation & amort. | −21 | −38 | −51 | −43 | −34 |
| EBIT | 177 | 51 | −103 | 124 | −89 |
| Net financials | −0 | 0 | −0 | 0 | 0 |
| Profit before tax | 177 | 51 | −103 | 125 | −88 |
| Tax | −0 | 2 | −2 | 7 | −0 |
| Net profit | 177 | 49 | −101 | 118 | −88 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 371 | 535 | 406 | 544 | 468 |
| Equity | 198 | 248 | 147 | 264 | 176 |
| Long-term debt | 0 | 2 | 0 | 0 | 0 |
| Short-term debt | 173 | 285 | 260 | 279 | 292 |
| Total debt | 173 | 287 | 260 | 279 | 292 |
EBITDA margin
-2.4%
This company
15.8%
Market median
-115% vs market
20202024
Equity ratio
37.6%
This company
38.2%
Market median
+2% vs market
20202024
Return on equity
-50.1%
This company
18.4%
Market median
-372% vs market
20202024
Net profit margin
-3.9%
This company
8.1%
Market median
-148% vs market
20202024
Asset turnover
4.83×
This company
1.12×
Market median
+331% vs market
20202024
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MW Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2016 | |
| Chairman | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Næss-Andresen As
VETTRE LEGEKONTOR AS Board members of VETTRE LEGEKONTOR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Margrethe Wilmers | Chief Executive Officer | 0 companies |
| Jorunn Hjertvik | Board of Directors | 0 companies |
| Solfrid Hulbak | Board of Directors | 0 companies |
| Marthe-Lise Næss-Andresen | Chairman | 0 companies |